KETOPROFEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ketoprofen, and what generic alternatives are available?
Ketoprofen is a drug marketed by Actavis Labs Fl Inc, Alkermes Gainesville, Mylan, Misemer, Rising, Teva, and Perrigo. and is included in ten NDAs.
The generic ingredient in KETOPROFEN is ketoprofen. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ketoprofen
A generic version of KETOPROFEN was approved as ketoprofen by TEVA on December 22nd, 1992.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KETOPROFEN?
- What are the global sales for KETOPROFEN?
- What is Average Wholesale Price for KETOPROFEN?
Summary for KETOPROFEN
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 109 |
| Patent Applications: | 533 |
| Drug Prices: | Drug price information for KETOPROFEN |
| Drug Sales Revenues: | Drug sales revenues for KETOPROFEN |
| DailyMed Link: | KETOPROFEN at DailyMed |
Recent Clinical Trials for KETOPROFEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Rennes University Hospital | PHASE4 |
| M.D. Anderson Cancer Center | PHASE2 |
| Siirt Training and Research Hospital | PHASE4 |
Pharmacology for KETOPROFEN
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for KETOPROFEN
Anatomical Therapeutic Chemical (ATC) Classes for KETOPROFEN
US Patents and Regulatory Information for KETOPROFEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | KETOPROFEN | ketoprofen | CAPSULE, EXTENDED RELEASE;ORAL | 075270-002 | Mar 24, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Perrigo | KETOPROFEN | ketoprofen | TABLET;ORAL | 075364-001 | Feb 7, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan | KETOPROFEN | ketoprofen | CAPSULE, EXTENDED RELEASE;ORAL | 075679-001 | Feb 20, 2002 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Alkermes Gainesville | KETOPROFEN | ketoprofen | CAPSULE, EXTENDED RELEASE;ORAL | 074879-001 | Dec 10, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | KETOPROFEN | ketoprofen | CAPSULE;ORAL | 074035-002 | Dec 31, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Misemer | KETOPROFEN | ketoprofen | CAPSULE;ORAL | 074014-001 | Jan 29, 1993 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | KETOPROFEN | ketoprofen | CAPSULE;ORAL | 073516-001 | Dec 22, 1992 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
